RESUMEN
The RH blood group is the most polymorphic and immunogenic blood group system. The RH locus is composed of 2 highly homologous genes: the RHD gene encoding the D polypeptide; and the RHCE gene, encoding C or c together with either E or e polypeptides. Numerous variants exist for both RHD and RHCE genes. Among them we were interested in the serological and molecular definition of numerous pre-published RHCE variants encountered in different populations. The identification of these variants is crucial to ensure the transfusion safety for patients expressing these variants. Here we propose a procedure to identify some of them and discuss the adequate transfusion strategy. This procedure has enable us to identify new variants to be presented at the symposium.
Asunto(s)
Tipificación y Pruebas Cruzadas Sanguíneas/métodos , Variación Genética , Sistema del Grupo Sanguíneo Rh-Hr/genética , Reacción a la Transfusión , Incompatibilidad de Grupos Sanguíneos/prevención & control , Tipificación y Pruebas Cruzadas Sanguíneas/normas , Etnicidad/genética , Francia , Frecuencia de los Genes , Genotipo , Humanos , Isoanticuerpos/análisis , Isoanticuerpos/sangre , Modelos Moleculares , Sistema del Grupo Sanguíneo Rh-Hr/química , Sistema del Grupo Sanguíneo Rh-Hr/clasificación , Sistema del Grupo Sanguíneo Rh-Hr/inmunología , Globulina Inmune rho(D)RESUMEN
The novel allele HLA-C*07:445 has 1 nucleotide change from HLA-C*07:01 at nucleotide 277 C>A in exon 2.
Asunto(s)
Alelos , Antígenos HLA-C/genética , Células Madre Hematopoyéticas/metabolismo , Donantes de Tejidos , Secuencia de Aminoácidos , Secuencia de Bases , Francia , Antígenos HLA-C/química , HumanosRESUMEN
In many clinical situations patients are dependent on blood transfusions. Occurrence of alloimmunization to blood group antigens (BGA) complicates the transfusion strategy and may be involved in clinical transfusion stalemate situations. B cell differentiation into antibody-secreting plasma cells is triggered by antigen and requires helper T cells which produce cytokines. Although antibodies implicated in BGA alloimmunization have been studied for many years, little is known about helper T cell responses that drive their production. Few studies on BGA specific T cell responses have been published today. This review summarizes the new developments in the field of cellular mechanisms implicated into antibody production. The definition of immunodominant peptides derived from RhD and Jk(a) BGAs, the cytokine patterns induced and the HLA class II molecules implicated in their presentation are analyzed. A tolerogenic route for RhD immunodominant peptides is experimented. Identification of such immunodominant peptides, the cytokine patterns induced and the HLA class II molecules implicated in their presentation, would facilitate the design of new therapeutic strategies including the specific control of alloimmunization with peptide antigen tolerogens or the ex-vivo induction of regulatory T cells.
Asunto(s)
Eritrocitos/inmunología , Inmunización , Isoanticuerpos/biosíntesis , Antígenos T-Independientes/inmunología , Antígenos de Grupos Sanguíneos/inmunología , Incompatibilidad de Grupos Sanguíneos , Transfusión Sanguínea , Anergia Clonal , Citocinas/fisiología , Epítopos de Linfocito T/inmunología , Antígenos HLA-D/inmunología , Humanos , Tolerancia Inmunológica , Epítopos Inmunodominantes/inmunología , Terapia de Inmunosupresión/métodos , Isoanticuerpos/inmunología , Linfocitos T Colaboradores-Inductores/inmunologíaRESUMEN
In 2004, the French Reference Centre for Rare Blood Groups and Immunohaematology (CNRGS) developed 7 types of activities: 1) Studies of complex Immunohaematology issues (IH), 2) Studies of rare blood phenotypes, 3) the transfusion of patients showing complex issues, 4) IH reactive control in consistency with the 98/79/CE European Directive, 5) European studies and expertise on reactives and techniques, 6) Biotechnologies applied to blood groups, in particular RH, KEL, FY, JK, DO and CO, 7) Implementation of allo-immunization research programs (cellular immunology and grafting issues). The CNRGS efficiency is based on the 'reference-research' link thanks to the Inserm partnership and direct applications to patients allowing to a better risk management and control.
Asunto(s)
Academias e Institutos , Alergia e Inmunología , Antígenos de Grupos Sanguíneos , Agencias Gubernamentales , Hematología , Academias e Institutos/estadística & datos numéricos , Adulto , Anemia/terapia , Anemia Hemolítica/etiología , Anemia Hemolítica/prevención & control , Informes Anuales como Asunto , Antígenos de Grupos Sanguíneos/clasificación , Antígenos de Grupos Sanguíneos/genética , Antígenos de Grupos Sanguíneos/inmunología , Incompatibilidad de Grupos Sanguíneos/diagnóstico , Incompatibilidad de Grupos Sanguíneos/prevención & control , Tipificación y Pruebas Cruzadas Sanguíneas/métodos , Tipificación y Pruebas Cruzadas Sanguíneas/normas , Transfusión Sanguínea/normas , Transfusión Sanguínea/estadística & datos numéricos , Unión Europea , Femenino , Francia , Genotipo , Agencias Gubernamentales/estadística & datos numéricos , Humanos , Indicadores y Reactivos/normas , Masculino , Tamizaje Masivo/organización & administración , Tamizaje Masivo/estadística & datos numéricos , Persona de Mediana Edad , Fenotipo , Garantía de la Calidad de Atención de Salud/organización & administración , Control de Calidad , Valores de Referencia , Reacción a la Transfusión , Inmunología del TrasplanteRESUMEN
BACKGROUND: The precise mechanism by which pretransplant blood transfusions may favorably influence the graft outcome in human transplantation remains unknown. Here, we explored whether the mechanism might be related to an alteration of cytokine response to transplantation antigens. METHODS: Eight patients awaiting kidney transplantation were selected to receive a single planned pretransplant blood transfusion. Before transfusion and 7 days after transfusion, peripheral blood mononuclear cells from these patients were isolated and in vitro stimulated in a one-way mixed leukocyte reaction (MLR) by using allogeneic fixed Epstein Barr virus-transformed cells as stimulators. RESULTS: The use of a semiquantitative reverse-transcriptase polymerase chain reaction cycle technique to analyze cytokine mRNAs revealed that allostimulation by donor cells clearly induced accumulation of interleukin (IL)-2, IL-4, interferon (IFN)-gamma, and IL-10 mRNA in peripheral blood mononuclear cells collected both before and after transfusion (eight of eight patients). However, both T helper 1 (IFN-gamma) and T helper 2 (IL-4) cytokine responses were more elevated after transfusion in eight of eight patients, as were IL-2 responses in five of eight patients. Such up-regulation of cytokine responses by transfusion was mostly directed against blood donor cells. Indeed, after stimulation by third-party cells, this up-regulation was both inconstant (two of three patients) and of less intensity, and no change was detected after stimulation by autologous cells (three of three patients). CONCLUSIONS: That IL-2, IL-4, and IFN-gamma responses to donor cells were increased by transfusion was further supported by results on cytokine secretion showing increased levels of IL-2 (P < 0.05), IFN-gamma (P = 0.054), and IL-4 (P < 0.05) proteins in supernatants of posttransfusion MLR as compared with pretransfusion MLR. In contrast, transfusion-induced changes in the amount of IL-10 mRNAs were not obvious and were quite variable from one patient to another.
Asunto(s)
Transfusión Sanguínea , Citocinas/genética , Trasplante de Riñón/inmunología , ARN Mensajero/genética , Adulto , Donantes de Sangre , Femenino , Prueba de Histocompatibilidad , Humanos , Interferón gamma/genética , Interleucina-10/genética , Interleucina-2/genética , Interleucina-4/genética , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Células TH1/inmunología , Células Th2/inmunología , Trasplante HomólogoRESUMEN
The French reference laboratory for rare blood groups (CNRGS) is working for all participants of the transfusion chain: from the donors to the recipients; from the French Establishment for Blood to medical laboratories; from hospital to the haemovigilance network; from governmental agencies to European structures. This laboratory is in charge of: (1) studies of complex problems of immunohaematology; (2) studies of rare blood group phenotypes; (3) reagents quality controls; (4) production of biological standards; (5) specific specimen banks; (6) molecular studies of blood group antigens and antibodies involved; (8) panels of reference cells or DNA; (9) international exchanges.
Asunto(s)
Antígenos de Grupos Sanguíneos , Tipificación y Pruebas Cruzadas Sanguíneas/normas , Laboratorios , Informes Anuales como Asunto , Anticuerpos Antiidiotipos/inmunología , Antígenos de Grupos Sanguíneos/genética , Antígenos de Grupos Sanguíneos/inmunología , Transfusión Sanguínea/normas , Congresos como Asunto , Francia , Frecuencia de los Genes , Indicadores y Reactivos/normas , Cooperación Internacional , Laboratorios/estadística & datos numéricos , Fenotipo , Control de Calidad , Estándares de Referencia , Sistema del Grupo Sanguíneo Rh-Hr/genética , Sistema del Grupo Sanguíneo Rh-Hr/inmunologíaRESUMEN
One hundred and forty five Mabs against RH antigens were tested. In this paper, we chose to detail reactivity of MoAbs directed against variant RBCs of the CNRGS collection for which we studied the molecular background. Because we developed procedures to identify variants of the RhD, RhC, RhE and Rhe antigens, we were especially interested in finding new monoclonal antibodies that could help us to characterize more accurately these variants. Therefore, we drew parallels between our procedures and results obtained with the 2001 workshop antibodies.
Asunto(s)
Anticuerpos Monoclonales/inmunología , Sistema del Grupo Sanguíneo Rh-Hr/inmunología , Especificidad de Anticuerpos , Reacciones Antígeno-Anticuerpo , Tipificación y Pruebas Cruzadas Sanguíneas/normas , Prueba de Coombs , Membrana Eritrocítica/inmunología , Variación Genética , Pruebas de Hemaglutinación , Humanos , Inmunoglobulina G/inmunología , Inmunoglobulina M/inmunología , Sistema del Grupo Sanguíneo Rh-Hr/genética , Serología/normasAsunto(s)
Anticuerpos Monoclonales/farmacocinética , Inmunosupresores/farmacocinética , Trasplante de Riñón/inmunología , Receptores de Interleucina-2/sangre , Adolescente , Anticuerpos Monoclonales/uso terapéutico , Basiliximab , Niño , Preescolar , Humanos , Inmunosupresores/uso terapéutico , Lactante , Recuento de Linfocitos , Estudios Prospectivos , Receptores de Interleucina-2/inmunología , Proteínas Recombinantes de Fusión/farmacocinética , Proteínas Recombinantes de Fusión/uso terapéutico , Factores de TiempoRESUMEN
BACKGROUND AND OBJECTIVES: The Duffy (FY) blood group system is controlled by four major alleles: FY*A and FY*B, the Caucasian common alleles, encoding Fy(a) and Fy(b) antigens; FY*X allele responsible for a poorly expressed Fy(b) antigen, and FY*Fy a silent predominant allele among Black population. Despite the recent development of a real-time fluorescent polymerase chain reaction (PCR) method for FY genotyping FY*X genotyping has not been described by this method. This study focused on the real-time FY*X genotyping development associated with a complete, one-step real-time FY genotyping, based on fluorescence resonance energy transfer (FRET) technology. MATERIALS AND METHODS: Seventy-two blood samples from Fy(a+b-) Caucasian blood donors were studied by real-time PCR only. Forty-seven Caucasian and Black individual blood samples, referred to our laboratory, were studied by PCR-RFLP and real-time PCR. For each individual, the result of the genotype was compared to the known phenotype. RESULTS: The FY*X allele frequency calculated in an Fy(a+b-) Caucasian blood donors population was 0.014. With the Caucasian and Black patient samples we found a complete correlation between PCR-RFLP and the real-time PCR method whatever the alleles combination tested. When the known phenotype was not correlated to FY*X genotype, the presence of the Fy(b) antigen was always confirmed by adsorption-elution. CONCLUSION: The real-time technology method is rapid and accurate for FY genotyping. From now, we are able to detect the FY*X allele in all the alleles combinations studied. Regarding its significant frequency, the detection of the FY*X allele is useful for the correct typing of blood donors and recipients considering the therapeutic use of blood units and the preparation of test red blood cells for antibody screening.
Asunto(s)
Población Negra/genética , Sistema del Grupo Sanguíneo Duffy/genética , Reacción en Cadena de la Polimerasa/métodos , Población Blanca/genética , Donantes de Sangre , Sistema del Grupo Sanguíneo Duffy/clasificación , Frecuencia de los Genes , Genotipo , HumanosRESUMEN
Here we show that Fas ligand, a death factor that plays a key role in peripheral T cell tolerance and homeostasis, can be induced in peripheral blood mononuclear cells from both newborns (cord) and adults. Indeed, stimulation of both populations by ionomycin and phorbol 12-myristate 13-acetate or through the T cell receptor (anti-CD3) leads to a selective lysis of targets transfected with Fas but not of the parental cell line. This lysis clearly involves a Fas-based mechanism inasmuch as it was correlated with the appearance of Fas ligand transcripts and competitively inhibited by a Fas-Fc fusion protein. Yet, the use of separated T cell populations revealed that both CD4+ and CD8+ T cells express this function in adults whereas the CD4 subset is primarily involved in lysis by a Fas-based mechanism in cord. Altogether these results suggest that distinct T cell subsets might be recruited to exert Fas-based lysis during T cell ontogeny. Furthermore, it is tempting to speculate that CD4+ T cells are primarily involved in peripheral T cell homeostasis and tolerance in early life because they are committed to exert Fas-based lysis before any antigen-priming. Finally, the model of Fas ligand exploration described herein might be of great help for the identification of Fas ligand dysregulation in various diseases in infants, including those patients with autoimmune lymphoproliferative syndrome in which Fas is functional.
Asunto(s)
Apoptosis/inmunología , Linfocitos T CD4-Positivos/inmunología , Glicoproteínas de Membrana/inmunología , Adulto , Linfocitos T CD4-Positivos/patología , Proteína Ligando Fas , Femenino , Humanos , Recién Nacido , Trabajo de Parto , Persona de Mediana Edad , Embarazo , Receptor fas/inmunologíaRESUMEN
Here we confirmed that IL2 mRNA expression in CD3-stimulated T cells is defective at birth. Because protein-tyrosine phosphorylation is an important part of signaling through CD3 and plays a key role in IL2 transcription, we further investigated whether impaired IL2 response to CD3 in newborns would be accompanied with an alteration of tyrosine phosphorylation. In this purpose, CD3-induced tyrosine phosphorylation was evaluated comparatively in newborn and adult cells by immunoblotting of total cellular extract with an antiphosphotyrosine antibody. Results show that, in both peripheral lymphocytes or purified CD4 T cells from both cord and adult, CD3 stimulation could induce small even significant tyrosine-phosphorylation. Tyrosine phosphorylation occurs as soon as 2' following CD3 ligation and was still evident up to 15-20'. Yet, by using a highly sensitive method to analyze CD3-induced accumulation of phosphorylated substrates, which consisted in adding pervanadate, an inhibitor of phosphatases, during the last 2 min of CD3 stimulation, we showed that the intensity of tyrosine phosphorylation was clearly decreased in cord cells. From these results, it is tempting to speculate that suboptimal capacities of cord T cells to up-regulate tyrosine phosphorylation might contribute to defective IL2 production in neonates.
Asunto(s)
Interleucina-2/genética , Linfocitos T/metabolismo , Tirosina/metabolismo , Adulto , Sangre Fetal , Regulación del Desarrollo de la Expresión Génica , Humanos , Recién Nacido , Fosforilación , ARN Mensajero/análisis , Tirosina/genéticaRESUMEN
Improvements in HLA-typing by DNA-based methods now allow accurate genotyping of unrelated bone marrow (UBM) donors and recipients and also definition of haplotypes. In this regard, B*5002 has been predicted in linkage disequilibrium with Cw*0602, DRB1*0406 and DQB1*0402 based on the frequency of allele coexistence. Here, we confirm this assumption by HLA genotyping of four informative families and three unrelated individuals. In the four families, the extended haplotype HLA-B*5002, -Cw*0602, -DRB1*0406, DQB1*0402 can be definitely assigned by the mode of heritance. Furthermore, this association of alleles was also found in the three B*5002 unrelated individuals. Knowledge of the frequent linkage disequilibrium of these rare alleles can improve UBM donor search strategies.
Asunto(s)
Trasplante de Médula Ósea/inmunología , Antígenos HLA-B/genética , Antígenos HLA-C/genética , Antígenos HLA-DQ/genética , Antígenos HLA-DR/genética , Salud de la Familia , Femenino , Antígenos HLA-B/inmunología , Antígenos HLA-C/inmunología , Antígenos HLA-DQ/inmunología , Cadenas beta de HLA-DQ , Antígenos HLA-DR/inmunología , Cadenas HLA-DRB1 , Haplotipos , Humanos , Desequilibrio de Ligamiento , Masculino , Donantes de Tejidos , Población Blanca/genéticaRESUMEN
We report the association of neurological and intestinal disorders with the reactivation of Epstein-Barr virus (EBV) in a child. This previously healthy 13-yr-old boy presented with pharyngitis and acute abdominal ileus. Laparotomy excluded a mechanical obstruction. Postoperatively, he suffered from prolonged intestinal obstruction, pandysautonomia, and encephalomyelitis. Histological examination of the appendix and a rectal biopsy taken 3 months after the onset showed an absence of ganglion cells (appendix) and hypoganglionosis (rectum), with a mononucleate inflammatory infiltrate in close contact with the myenteric neural plexuses. EBV-PCR was positive in the blood and cerebrospinal fluid, and in situ hybridization with the Epstein-Barr virus encoded RNA probe showed positive cells throughout the appendix wall including the myenteric area, in a mesenteric lymph node, and in the gastric biopsies. EBV spontaneous lymphocytic proliferation was noted in the blood. The serology for EBV showed previous infection but anti-early antigen antibodies were present. No immunodeficiency was found. Neurological and GI recovery occurred after 6 months of parenteral nutrition and bethanechol. The omnipresence of EBV associated with the neurointestinal symptoms suggest that the virus was the causal agent. This is the first documented case of acquired hypoganglionnosis due to EBV reactivation.
Asunto(s)
Enfermedades del Sistema Nervioso Autónomo/etiología , Infecciones por Virus de Epstein-Barr/complicaciones , Mononucleosis Infecciosa/complicaciones , Seudoobstrucción Intestinal/etiología , Enfermedad Aguda , Adolescente , Infecciones por Virus de Epstein-Barr/diagnóstico , Humanos , MasculinoRESUMEN
Six unrelated individuals of Afro-Caribbean origin, whose red cells have a marked reduction of the Rhe antigen expression, have been identified. All exhibited the same serological profile with anti-e monoclonal antibodies and lacked expression of the high frequency e-related antigen hrS. Transcripts and genomic analysis showed that these phenotypes resulted from the presence of two new RHCE alleles, ceMO and cEMI. The ceMO allele corresponded to a RHce gene carrying a G667T mutation (exon 5) and was detected at the homozygous state in sample 1 and at the heterozygous state in samples 2-6. The G667T mutation resulted in a Val223Phe substitution on the Rhce polypeptide, in close proximity to Ala226 (e-antigen polymorphism), which might account for the altered expression of e. The ceMO allele is also associated with the lack of expression of the hrS antigen. The absence of the hrS antigen expression may have implications in transfusion as hrS-negative individuals may develop clinically significant antibodies. The cEMI allele corresponded to a silent RHE allele carrying a nine nucleotide deletion within exon 3 and was detected at the heterozygous state in sample 2. This deletion resulted in a shortened polypeptide of 414 residues (instead of 417) that was absent (or severely reduced) at the red cell surface, as the E antigen was undetectable using serology and Western blot analysis with anti-E reagents. In DNA-based polymerase chain reaction genotyping for RHE determination, the cEMI allele provided a false positive result as the cells carrying this allele are serologically phenotyped as E-negative. The incidence of this allele in the Black population is unknown but, as shown already for D genotyping, one must exercise caution when genotyping is performed to detect the e/E polymorphism.